“amicus-therapeutics” Archives

in
Entry Author Date Location
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Entrada Therapeutics Nabs $59M for Drugs that Gain “Entry” to Cells 12/18/18 Boston
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Amicus Shells Out $100M For Celenex And Dives Into Gene Therapy 09/20/18 New York
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
FDA, Following EMA, Nixes Amicus’ Plans for Speedy OK of Pompe Drug 09/10/18 New York
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals 08/10/18 New York
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
Pompe Disease Patients on Amicus Drug Continue to Improve in Study 02/07/18 New York
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3 09/13/17 New York
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition 07/06/16 New York
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug 05/31/16 New York
At Long Last, First Drug Approval in Sight for Amicus 04/01/16 New York
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Page 1 of 2 next page »